Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4475 USD | -2.31% | -3.31% | -69.35% |
05-06 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
05-06 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-69.35% | 14.26M | |
-1.62% | 90.85B | |
-1.05% | 39.02B | |
-11.20% | 33.46B | |
+61.85% | 26.38B | |
-20.75% | 14.51B | |
-6.35% | 13.22B | |
-11.42% | 11.65B | |
-47.67% | 10.57B | |
+6.97% | 9.23B |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- Redhill Biopharma Says FDA Approved Supplemental New Drug Application for Talicia